Are you at risk for developing heart failure? If you have hypotension, you may be!

People whose blood pressure drops rapidly when they move from lying down to standing, known as orthostatic hypotension, may have a higher risk of developing heart failure.

Performing CT scans in the emergency department for patients experiencing dizziness may not be worth the expense – an important finding from Henry Ford Hospital researchers as hospitals across the country look for ways to cut costs without sacrificing patient care.

Approximately 50,000 Americans suffer from multiple system atrophy (MSA) a rare condition that attacks the autonomic nervous system. To raise awareness and donations for the MSA Support Group a dance fundraising event will be held on May 21, 2012 in Paducah, Ky.

PHILADELPHIA, September 13, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that the United States Food and Drug Administration today posted an update on its website related to ProAmatine (known generically as midodrine), a medicine approved for the treatment of symptomatic orthostatic hypotension. Notably, the FDA clarified that the FDA's prior announcement related to midodrine "did not represent the actual withdrawal of the medication from the market." Rather, the FDA stated that it "represented a step in the regulatory process." To view this FDA statement, visit: http://www.fda.gov/Drugs/DrugSafety/ucm225444.htm "Shire is very pleased that FDA has stated that 'continued patient access to midodrine is a key agency priority' and that the FDA has taken action allowing midodrine to remain accessible to patients and their families who rely on this medicine," said Jeffrey Jonas, M.D., Senior Vice Presi